Cosmetovigilance Market (By Service Type: Pre-marketing Services, Post-marketing Services; By Categories: Skincare, Makeup, Haircare, Perfumes and deodorants, Hair colorants, Others; By Phase Type: Pre-clinical Phase I, Phase II, Phase III, Phase IV; By Service Provider: In-house, Contract Outsourcing) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Cosmetovigilance Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Cosmetovigilance Market, by Service Type, 2024-2033
8.1.1. Pre-marketing Services
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Post-marketing Services
8.1.2.1. Market Revenue and Forecast (2021-2033)
9.1. Cosmetovigilance Market, by Categories, 2024-2033
9.1.1. Skincare
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Makeup
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Haircare
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Perfumes and deodorants
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Hair colorants
9.1.5.1. Market Revenue and Forecast (2021-2033)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2021-2033)
10.1. Cosmetovigilance Market, by Phase Type, 2024-2033
10.1.1. Pre-clinical
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Phase I
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Phase II
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Phase III
10.1.4.1. Market Revenue and Forecast (2021-2033)
10.1.5. Phase IV
10.1.5.1. Market Revenue and Forecast (2021-2033)
11.1. Cosmetovigilance Market, by Service Provider, 2024-2033
11.1.1. In-house
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Contract Outsourcing
11.1.2.1. Market Revenue and Forecast (2021-2033)
12.1. North America
12.1.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.1.2. Market Revenue and Forecast, by Categories (2021-2033)
12.1.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.1.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.1.5.2. Market Revenue and Forecast, by Categories (2021-2033)
12.1.5.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.1.5.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.1.6.2. Market Revenue and Forecast, by Categories (2021-2033)
12.1.6.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.1.6.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.2.2. Market Revenue and Forecast, by Categories (2021-2033)
12.2.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.2.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.2.5.2. Market Revenue and Forecast, by Categories (2021-2033)
12.2.5.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.2.5.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.2.6.2. Market Revenue and Forecast, by Categories (2021-2033)
12.2.6.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.2.6.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.2.7.2. Market Revenue and Forecast, by Categories (2021-2033)
12.2.7.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.2.7.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.2.8.2. Market Revenue and Forecast, by Categories (2021-2033)
12.2.8.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.2.8.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.3.2. Market Revenue and Forecast, by Categories (2021-2033)
12.3.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.3.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.3.5.2. Market Revenue and Forecast, by Categories (2021-2033)
12.3.5.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.3.5.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.3.6.2. Market Revenue and Forecast, by Categories (2021-2033)
12.3.6.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.3.6.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.3.7.2. Market Revenue and Forecast, by Categories (2021-2033)
12.3.7.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.3.7.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.3.8.2. Market Revenue and Forecast, by Categories (2021-2033)
12.3.8.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.3.8.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.4.2. Market Revenue and Forecast, by Categories (2021-2033)
12.4.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.4.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.4.5.2. Market Revenue and Forecast, by Categories (2021-2033)
12.4.5.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.4.5.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.4.6.2. Market Revenue and Forecast, by Categories (2021-2033)
12.4.6.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.4.6.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.4.7.2. Market Revenue and Forecast, by Categories (2021-2033)
12.4.7.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.4.7.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.4.8.2. Market Revenue and Forecast, by Categories (2021-2033)
12.4.8.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.4.8.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.5.2. Market Revenue and Forecast, by Categories (2021-2033)
12.5.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.5.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.5.5.2. Market Revenue and Forecast, by Categories (2021-2033)
12.5.5.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.5.5.4. Market Revenue and Forecast, by Service Provider (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Service Type (2021-2033)
12.5.6.2. Market Revenue and Forecast, by Categories (2021-2033)
12.5.6.3. Market Revenue and Forecast, by Phase Type (2021-2033)
12.5.6.4. Market Revenue and Forecast, by Service Provider (2021-2033)
13.1. Poseidon CRO
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. AxeRegel
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. PharSafer
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. AB Cube
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Aixial Group
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Di Renzo
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Pharmathen
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Skill Pharma
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. OC Vigilance
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Preclinical
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client